Doximity Shares Drop 16.8% on 4.5M Volume as Analysts Upgrade
Shares of Doximity plunged 16.78% on volume exceeding 4.5 million shares, prompting upgrades from Wells Fargo, Royal Bank of Canada and Needham with overweight and moderate buy ratings. Canaccord Genuity set a $34 price target, implying potential upside of 22.6% from current levels.
1. Stock Price Movement and Trading Range
On February 9, Doximity shares opened at $23.69 following a prior close of $33.32, marking a 16.78% decline. During the session, prices fluctuated between $23.66 and $27.88 as investors reacted to the sharp sell-off.
2. Analyst Rating Changes and Price Targets
Several firms upgraded Doximity after the drop: Wells Fargo raised its rating to overweight with a $55 target, Royal Bank of Canada and Needham assigned moderate buy ratings, while Canaccord Genuity set a $34 target. Wall Street Zen downgraded the stock to hold and Weiss Ratings maintained a hold (C+) grade.
3. Trading Volume and Market Capitalization
Today’s trading volume reached 22.18 million shares on the NYSE, underscoring heightened investor interest. Doximity’s market capitalization stands around $5.2 billion, reflecting current valuation pressures.
4. Volatility Context and Competitive Landscape
Over the past year, Doximity shares have ranged from a low of $23.66 to a high of $85.21, highlighting significant volatility. The platform competes with peers such as Teladoc and Amwell in the digital healthcare technology sector.